HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Jean-Claude Monboisse Selected Research
Jean-Claude Monboisse Research Topics
Disease
13
Neoplasms (Cancer)
01/2018 - 06/2002
12
Melanoma (Melanoma, Malignant)
01/2018 - 06/2002
2
Inflammation (Inflammations)
01/2019 - 01/2003
2
Rhabdomyosarcoma
01/2017 - 01/2016
1
Squamous Cell Carcinoma of Head and Neck
04/2019
1
Carcinogenesis
01/2019
1
Neoplasm Metastasis (Metastasis)
02/2004
1
Diabetes Mellitus
05/2002
1
Atherosclerosis
05/2002
Drug/Important Bio-Agent (IBA)
7
Collagen
IBA
01/2018 - 01/2003
7
Peptides (Polypeptides)
IBA
01/2018 - 01/2003
3
Peptide Hydrolases (Proteases)
FDA Link
01/2019 - 06/2002
3
type IV collagen alpha3 chain (Goodpasture antigen)
IBA
03/2013 - 12/2004
3
Collagen Type IV (Type IV Collagen)
IBA
01/2005 - 06/2002
3
Matrix Metalloproteinases (MMPs)
IBA
01/2005 - 06/2002
2
Proteins (Proteins, Gene)
FDA Link
04/2019 - 05/2002
2
Elastin
IBA
01/2019 - 06/2002
2
Antineoplastic Agents (Antineoplastics)
IBA
01/2018 - 03/2010
2
Integrins
IBA
01/2018 - 01/2016
2
YSNSG cyclopeptide
IBA
03/2010 - 12/2006
1
Ions
IBA
04/2019
1
Fibril-Associated Collagens (FACIT Collagen)
IBA
01/2016
1
Enzymes
IBA
02/2015
1
Fibrinolysin
FDA Link
02/2015
1
matrigel
IBA
02/2007
1
Tissue Plasminogen Activator (Alteplase)
FDA Link
12/2004
1
Plasminogen Activators (Plasminogen Activator)
IBA
12/2004
1
Plasminogen
IBA
12/2004
1
Cyclic AMP (AMP, Cyclic)
IBA
12/2004
1
Urokinase-Type Plasminogen Activator (Urokinase)
FDA Link
12/2004
1
Catalytic RNA (Ribozymes)
IBA
02/2004
1
Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)
IBA
02/2004
1
Tissue Inhibitor of Metalloproteinases
IBA
02/2004
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
02/2004
1
Metalloproteases (Metalloproteinases)
IBA
02/2004
1
progelatinase
IBA
06/2002
1
Integrin alphaVbeta3
IBA
06/2002
1
Matrix Metalloproteinase 14 (MT1-MMP)
IBA
06/2002
1
cyclohexenoesculetin-beta-galactoside (S-Gal)
IBA
06/2002
1
valyl-glycyl-valyl-alanyl-prolyl-glycine
IBA
06/2002
Therapy/Procedure
1
Therapeutics
02/2004